TG THERAPEUTICS, INC. Increase (Decrease) in Prepaid Expense and Other Assets
TG THERAPEUTICS, INC. (TGTX) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$8.15 thousand for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2012-05-14
- TG THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2012-03-31 was -$8.15K.
- TG THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2011-12-31 was $36.91K.
- TG THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2011-09-30 was -$16.07K.
- TG THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2011-06-30 was -$24.44K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 119 month | Increase (Decrease) in Prepaid Expense and Other Assets 122 month |
|---|---|---|---|---|---|---|
| 2012-03-31 | -$8.15K 10-Q · filed 2012-05-14 | $28.77K derived: sum of 2 quarters · filed 2012-05-14 | $12.70K derived: sum of 3 quarters · filed 2012-05-14 | -$11.74K 10-Q · filed 2012-05-14 | ||
| 2011-12-31 | $36.91K derived: 8-K/A 12 month − 10-Q 9 month · filed 2012-03-16 | $20.85K derived: sum of 2 quarters · filed 2012-03-16 | -$3.59K derived: sum of 3 quarters · filed 2012-05-14 | -$3.59K 8-K/A · filed 2012-03-16 | ||
| 2011-09-30 | -$16.07K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-14 | -$40.51K derived: sum of 2 quarters · filed 2012-05-14 | -$40.51K 10-Q · filed 2011-11-14 | -$78.00K 10-Q · filed 2011-11-14 | ||
| 2011-06-30 | -$24.44K derived: 10-Q 12 month − 3 quarters · filed 2012-05-14 | -$24.44K 10-Q/A · filed 2011-09-14 | -$61.93K 10-Q/A · filed 2011-09-14 | |||
| 2010-09-30 | -$10.27K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-14 | -$60.61K 10-Q · filed 2011-11-14 | ||||
| 2010-06-30 | -$50.34K 10-Q/A · filed 2011-09-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |